Greater Cannabis Co (Greater Cannabis Co) Momentum Rank : 0 (As of Jun. 07, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co Momentum Rank?

Greater Cannabis Co has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Greater Cannabis Co Momentum Rank Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Greater Cannabis Co (Greater Cannabis Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208

Website

https://www.gcanrx.com

Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.

Executives

Jimmy Wayne Anderson

10 percent owner

501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701